- Home
- BNR vs DARE Comparison
BNR vs DARE Comparison
Compare BNR & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- DARE
- Stock Information
- Founded
- BNR 2014
- DARE 2015
- Country
- BNR China
- DARE United States
- Employees
- BNR N/A
- DARE N/A
- Industry
- BNR Medical Specialities
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- BNR Health Care
- DARE Health Care
- Exchange
- BNR Nasdaq
- DARE Nasdaq
- Market Cap
- BNR 38.3M
- DARE 26.3M
- IPO Year
- BNR 2020
- DARE N/A
- Fundamental
- Price
- BNR $4.68
- DARE $2.56
- Analyst Decision
- BNR
- DARE Strong Buy
- Analyst Count
- BNR 0
- DARE 3
- Target Price
- BNR N/A
- DARE $12.50
- AVG Volume (30 Days)
- BNR 17.4K
- DARE 4.4M
- Earning Date
- BNR 08-21-2025
- DARE 08-11-2025
- Dividend Yield
- BNR N/A
- DARE N/A
- EPS Growth
- BNR N/A
- DARE N/A
- EPS
- BNR N/A
- DARE N/A
- Revenue
- BNR $72,112,038.00
- DARE $25,909.00
- Revenue This Year
- BNR $136.32
- DARE $74,787.57
- Revenue Next Year
- BNR N/A
- DARE $141.76
- P/E Ratio
- BNR N/A
- DARE N/A
- Revenue Growth
- BNR 0.53
- DARE N/A
- 52 Week Low
- BNR $2.18
- DARE $2.11
- 52 Week High
- BNR $7.90
- DARE $9.19
- Technical
- Relative Strength Index (RSI)
- BNR 69.57
- DARE 46.80
- Support Level
- BNR $4.47
- DARE $2.44
- Resistance Level
- BNR $4.96
- DARE $9.19
- Average True Range (ATR)
- BNR 0.25
- DARE 0.60
- MACD
- BNR 0.11
- DARE 0.03
- Stochastic Oscillator
- BNR 84.31
- DARE 6.49
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.